STOCK TITAN
  1. Home
  2. Sec-filings
  3. PCSC
  4. [SCHEDULE 13G] Perceptive Capital Solutions Corp Passive Investment Disclosure (>5%)

Andreessen Horowitz (PCSC) entities disclose 5.2% beneficial stake in Freenome common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Freenome, Inc. reports that investment entities affiliated with Andreessen Horowitz have filed a Schedule 13G disclosing their beneficial ownership of the company’s common stock. The filing covers multiple Delaware limited partnerships and LLCs, as well as Marc L. Andreessen and Benjamin A. Horowitz.

The positions include 3,327,525 shares held by AH Bio Fund I, L.P., 1,038,814 shares held by Andreessen Horowitz LSV Fund II, L.P., 6,207 shares held by CLF Partners, LP, and 1,199,053 shares held by AH Parallel Fund IV, L.P., each with sole voting and dispositive power through their respective general partners. Based on 107,446,814 shares of common stock outstanding as of July 20, 2026, Marc Andreessen and Ben Horowitz are each reported as beneficially owning 5,571,599 shares, or 5.2% of the common stock, through their managing member roles in the general partner entities.

Positive

  • None.

Negative

  • None.
Shares outstanding 107,446,814 shares Common stock outstanding as of July 20, 2026, from a Current Report on Form 8-K
Andreessen beneficial ownership 5,571,599 shares (5.2%) Shares of Freenome common stock beneficially owned by Marc L. Andreessen
Horowitz beneficial ownership 5,571,599 shares (5.2%) Shares of Freenome common stock beneficially owned by Benjamin A. Horowitz
AH Bio Fund I position 3,327,525 shares (3.1%) Common stock held by AH Bio Fund I, L.P. for itself and as nominee for AH Bio I-B
AH LSV Fund II position 1,038,814 shares (1.0%) Common stock held by Andreessen Horowitz LSV Fund II, L.P. and its parallel funds
AH Parallel Fund IV position 1,199,053 shares (1.1%) Common stock held by AH Parallel Fund IV, L.P. and its related funds
beneficially owned financial
"sets forth the aggregate number of shares of common stock of the Issuer beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power financial
"may be deemed to have sole power to vote and sole power to dispose of shares"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
shared voting power financial
"may be deemed to have shared voting and shared dispositive power over the shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Schedule 13G regulatory
"The names of the persons filing this report (collectively, the "Reporting Persons")"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
power of attorney regulatory
"Exhibit 24.1 Power of Attorney for Marc L. Andreessen, dated June 23, 2023."
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What stake in Freenome, Inc. (PCSC) is reported by Andreessen Horowitz affiliates?
Andreessen Horowitz affiliates report beneficial ownership of Freenome common stock through several funds, including 3,327,525 shares by AH Bio Fund I, 1,038,814 shares by LSV Fund II, 6,207 shares by CLF Partners, and 1,199,053 shares by AH Parallel Fund IV, all with sole voting and dispositive power.

How many Freenome (PCSC) shares do Marc Andreessen and Ben Horowitz beneficially own?
Marc Andreessen and Ben Horowitz each are reported as beneficially owning 5,571,599 shares of Freenome common stock. This represents 5.2% of the outstanding common stock for each, based on 107,446,814 shares outstanding as of July 20, 2026.

What percentage of Freenome (PCSC) does AH Bio Fund I, L.P. own?
AH Bio Fund I, L.P. is reported as beneficially owning 3,327,525 shares of Freenome common stock, representing 3.1% of the class. These shares are held for itself and as nominee for AH Bio Fund I-B, L.P., with sole voting and dispositive power attributed to its general partner.

How many Freenome (PCSC) shares are outstanding according to this Schedule 13G?
The filing states that 107,446,814 shares of Freenome common stock were outstanding as of July 20, 2026. This figure comes from a Current Report on Form 8-K and is used to calculate the ownership percentages reported by each Andreessen Horowitz-related entity and individual.

Do Marc Andreessen and Ben Horowitz hold Freenome (PCSC) shares directly?
Marc Andreessen and Ben Horowitz are reported as beneficial owners through fund structures, not as direct record holders. They are managing members of the general partner entities (such as AH EP Bio I and AH Equity LSV II), which may be deemed to share voting and dispositive power over the Freenome shares held by the affiliated funds.

What is the role of the general partners in the Freenome (PCSC) holdings?
General partners such as AH Equity Partners Bio I, L.L.C. and AH Equity Partners V, L.L.C. may be deemed to have sole power to vote and dispose of Freenome shares held by their respective funds. Andreessen and Horowitz, as managing members of these general partners, may share voting and dispositive power over those positions.



35661P100
(CUSIP Number)
07/20/2026
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)


schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



AH Bio Fund I, L.P.
Signature:/s/ Phil Hathaway
Name/Title:By AH Equity Partners Bio I, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 1)
Date:07/27/2026
AH Equity Partners Bio I, L.L.C.
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Chief Operating Officer
Date:07/27/2026
Andreessen Horowitz LSV Fund II, L.P.
Signature:/s/ Phil Hathaway
Name/Title:By AH Equity Partners LSV II, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 2)
Date:07/27/2026
AH Equity Partners LSV II, L.L.C.
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Chief Operating Officer
Date:07/27/2026
CLF Partners, LP
Signature:/s/ Phil Hathaway
Name/Title:By AH Equity Partners V, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer
Date:07/27/2026
AH Equity Partners V, L.L.C.
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Chief Operating Officer
Date:07/27/2026
AH Parallel Fund IV, L.P.
Signature:/s/ Phil Hathaway
Name/Title:By AH Equity Partners IV (Parallel), L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 3)
Date:07/27/2026
AH Equity Partners IV (Parallel), L.L.C.
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Chief Operating Officer
Date:07/27/2026
Marc L. Andreessen
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Attorney-in-Fact
Date:07/27/2026
Benjamin A. Horowitz
Signature:/s/ Phil Hathaway
Name/Title:By Phil Hathaway, Attorney-in-Fact
Date:07/27/2026

Comments accompanying signature: Note 1: AH Bio Fund I, L.P. for itself and as nominee for AH Bio Fund I-B, L.P. Note 2: Andreessen Horowitz LSV Fund II, L.P. for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. Note 3: AH Parallel Fund IV, L.P. for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B L.P. and AH Parallel Fund IV-Q, L.P.
Exhibit Information

Exhibit 24.1 Power of Attorney for Marc L. Andreessen, dated June 23, 2023. Exhibit 24.2 Power of Attorney for Benjamin A. Horowitz, dated June 22, 2023. Exhibit 99.1 Joint Filing Agreement

Source: View Original Filing on SEC EDGAR